Who invested in Waypoint Bio

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$35Mraised across 2 rounds since 2024, from 2 sources

$15MSeed$20MSeries A

Latest round: Series A, $20MMay 2026
Step-upi: 1.4×
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$15MSeed$20MSeries A

First round: Seed, $15M
Biggest round: $20M
Between rounds: 23 months

The rounds

May 2026
Series A$20M3 new2 returning
Source recorded
Jun 2024
Seed$15M3 new
Source recorded

Founders and team

From Waypoint Bio's own website: 7 on the team.

Patrick KaifoshChief Technology Officer
Tinsley MaierChief of Staff
Ashley ChuiSenior Scientist
Cassandra KonturPrincipal Scientist
Ellie NovogradacAssociate Scientist
Megha SahPrincipal Scientist
Reeti SanghrajkaSenior Scientist

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2024Series A2026

Everyone who backed them

Village GlobalVC firm2rounds

Hummingbird VenturesVC firm2rounds

General CatalystVC firm1round

Lux CapitalVC firm1round

Amplify PartnersVC firm1round

Fifty YearsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Waypoint Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.